Haemonetics Corporation (HAE) Stock Overview
NYSE · Healthcare · Medical Devices
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About Haemonetics Corporation
Haemonetics Corporation, a medical technology company, provides a suite of hospital technologies solutions. The company operates through Plasma, Blood Center, and Hospital segments. It provides automated plasma collection systems, donor management software, and supporting software solutions,…
Source: Yahoo Finance
Sector & Industry
Haemonetics Corporation operates in the Healthcare sector, within the Medical Devices industry group. It is listed on the NYSE exchange.
Haemonetics Corporation at a Glance
| Company | Haemonetics Corporation |
| Ticker | HAE |
| Exchange | NYSE |
| Currency | USD |
| Price | $102.92 |
| Market cap | $4.68B |
| P/E ratio (trailing) | 49.72 |
| EPS (trailing) | $2.07 |
| 52-week high | $109.57 |
| 52-week low | $47.32 |
| Dividend yield | — |
| Ex-dividend date | — |
| Beta | 0.54 |
| Return on equity (ROE) | 11.20% |
| Debt-to-equity | 140.26% |
| Average volume | 826,053 |
| Shares outstanding | 45.50M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Employees | 3,009 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Frequently Asked Questions
- What is Haemonetics Corporation's current P/E ratio?
- Haemonetics Corporation (HAE) has a trailing P/E ratio of 49.72 as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is Haemonetics Corporation's market capitalisation?
- Haemonetics Corporation's market cap is $4.68B based on our latest snapshot. See how it ranks by market cap →
- What is HAE's 52-week range?
- Over the past 52 weeks, HAE has traded between $47.32 and $109.57. What does the 52-week range mean? →
- How volatile is Haemonetics Corporation compared to the market?
- Haemonetics Corporation has a beta of 0.54, meaning it has historically moved less than the broader market. What does beta measure? →
- Does Haemonetics Corporation pay a dividend?
- Haemonetics Corporation does not currently pay a dividend according to our latest data.
- What exchange is HAE listed on?
- HAE is listed on the NYSE. Browse all NYSE-listed stocks →
- What sector is Haemonetics Corporation in?
- Haemonetics Corporation is classified in the Healthcare sector. Compare with Healthcare peers →
For compound interest, percentage change and other investing maths, try our free online calculators.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →Philip Fisher on what makes a business worth owning for the long term.
Check Price →